Navigation Links
Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
Date:2/12/2008

CORONA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, today announced that its New Drug Application (NDA) for silodosin, a novel alpha(1)- adrenoreceptor antagonist, has been accepted for filing by the U.S. Food and Drug Administration (FDA). Watson is seeking marketing approval of silodosin from the FDA for the treatment of the signs and symptoms associated with benign prostatic hyperplasia (BPH), or enlarged prostate. Watson anticipates that the FDA will take action on its application in the fourth quarter 2008.

Silodosin was designed to decrease urinary resistance and improve dysuria (difficulty or pain in urination) associated with BPH. In clinical trials, silodosin demonstrated a very low level of the most highly-reported cardiovascular and blood pressure-related side effects associated with existing BPH treatments, including dizziness and first-dose syncope (fainting).

"This filing highlights Watson's capabilities in new drug development and our commitment to this product, providing solutions to the millions of men with BPH symptoms," said Paul Bisaro, Watson's President and Chief Executive Officer. "Watson is expanding the portfolio it offers to urologists and their patients, focusing on symptom management that makes a big difference in their day-to-day lives."

Watson submitted the filing for silodosin with data from two Phase 3 multi-center (88 sites), randomized, double-blind, placebo-controlled trials that evaluated a total of 923 patients with signs and symptoms of BPH for 12 weeks. The trials demonstrated that a once daily 8mg dose of silodosin given for 12 weeks provided significant relief of BPH symptoms, compared with place
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
2. Watson Launches Generic Biaxin(R) XL
3. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
4. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
5. Emisphere Technologies Announces Positive Results From Animal Studies on Oral B12 Using eligen(R) Technology
6. PTC Therapeutics Announces Publication of Preclinical Data in PNAS
7. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
8. TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
9. Inverseon Announces Positive Phase IIa Asthma Study
10. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
11. N30 Pharma Announces Successful Initiation of Human Studies With N30-201
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Today, Wall Street Reports announced new ... ), Health Management Associates Inc. (NYSE: HMA ), ... Inc. (NASDAQ: ISIS ), and Trius Therapeutics Inc. ... charge - including full price targets, industry analysis and analyst ... Inc. Research Report On June 7, 2013, Gilead ...
(Date:6/18/2013)... , June 18, 2013 Apama ... on the development of next-generation atrial fibrillation technologies, ... 8295902 by the US Patent and Trademark Office ... low profile electrode assemblies for use on expandable ... or other surgical procedures. "We are ...
(Date:6/17/2013)... June 17, 2013 Velplex, LLC announced this ... technology platform that connects buyers and sellers of ... industry leader. Why? It,s because the ... intimately familiar with the dental industry. They have 50 ... have diligently worked to negotiate some of the best ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
(Date:6/18/2013)... A new $119 million industry is taking the ... redefining the way consumers get their seafood. , ... chefs on the Emerald Coast panhandle of Northwest Florida ... the promising industry of aquaculture. , The word “sustainable” ... to fully partake in the effort, especially when it ...
(Date:6/18/2013)... David Connett, DO, vice dean, medical ... the College of Osteopathic Medicine of the Pacific (COMP) ... president of the Osteopathic Medical Board of California ... Connett, a 1984 alumnus of COMP, to the OMBC ... to the position during a conference call. , In ...
(Date:6/18/2013)... 18, 2013 -- Lauren Sciences, a privately-held biotechnology ... platform technology, announced today that it was independently ... with its V-Smart Platform, and selected as a ... Group. , The report, " Early ... Emerging Companies ," features companies MCD Group independently ...
(Date:6/18/2013)... their first patients in the ROADSTER Study, a global, ... help clear blockages in carotid arteries and prevent strokes. ... the United States are diagnosed with blockages, or plaques ... can slow or even stop blood flow to the ... a "brain attack." , Current treatment options include ...
(Date:6/18/2013)... scrambling to gather data for the FDA to support ... injury in the United States. The University of Rochester ... the Journal of Neurotrauma that it might ... of one., Jeffrey J. Bazarian, M.D., M.P.H., an associate ... first to show that measuring a combination of two ...
Breaking Medicine News(10 mins):Health News:New $119 Million Industry Swimming Up the East Coast 2Health News:UH Case Medical Center among first to enroll patients for global carotid artery trial 2
... Mitt,Romney is heading back to the Granite State ... of legislation that would provide health care for,8,700 ... 25,2007] Despite recent polls showing that seven in ... health insurance to 10 million children,across the country ...
... Spending Goes to Global Health, ASPEN, Colo., ... U.S. invested $9.3 billion last year in global ... That amount,represents 8% of the $116 billion that ... in 2006., Mary Woolley, Research!America,s president, announced ...
... in the University of Iowa College of Nursing, and ... funded for a four-year $1.2 million grant to ensure ... caring for elders with mental health issues. , The ... form the Geropsychiatric Nursing Collaborative, are in the UI ...
... Oct. 4 In a departure from,current FDA ... women and women of childbearing age to increase ... a highly potent,neurotoxin and other contaminants commonly found ... women to eat more fish without,mentioning the documented ...
... meets crucial need in ... exploding ... Services, Inc,-- an online education, enrollment, and incentive support platform ... 2007.,The Fontis Health platform (http://www.fontishealth.com ) simplifies the,administration and ...
... was issued,today by the law firms Schiffrin Barroway Topaz ... Out of public health concerns and in light of ... contaminated ground beef products,SCHIFFRIN BARROWAY TOPAZ & KESSLER, LLP ... for victims of E. coli poisoning to document,their injuries ...
Cached Medicine News:Health News:DNC: Romney an (S)CHIP Off the Bush Republican Block 2Health News:DNC: Romney an (S)CHIP Off the Bush Republican Block 3Health News:U.S. Invests $9.3 Billion in Research to Improve Health Globally 2Health News:Fontis Health Launches Online HSA Support System 2Health News:Establishment of Topps Meat Recall Registry for Victims of E. Coli Poisoning 2Health News:Establishment of Topps Meat Recall Registry for Victims of E. Coli Poisoning 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: